Drug-induced cholestasis: causative agents and challenges in diagnosis and management
Drug-induced liver injury (DILI) is an adverse reaction to drugs and other xenobiotics that can have serious consequences and jeopardise progress in pharmacological therapy. While DILI is predominantly hepatocellular, a non-negligible percentage of patients who present with cholestatic damage. Mixed...
Main Authors: | Jose M. Pinazo-Bandera, Juan Pedro Toro-Ortiz, Raúl J. Andrade, Miren García-Cortés |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2023-09-01
|
Series: | Exploration of Digestive Diseases |
Subjects: | |
Online Access: | https://www.explorationpub.com/Journals/edd/Article/100527 |
Similar Items
-
Inflammatory Bowel Disease Therapies and Acute Liver Injury
by: Roberto Catanzaro, et al.
Published: (2024-06-01) -
Drug-Induced Liver Injury from Herbal Liver Detoxification Tea
by: Bilal Niazi, et al.
Published: (2022-11-01) -
Ticlopidine-induced cholestatic hepatitis: A case report and review of the literature
by: Luigi Anastasio, et al.
Published: (2012-10-01) -
Oral clindamycin causing acute cholestatic hepatitis without ductopenia: a brief review of idiosyncratic drug-induced liver injury and a case report
by: Harsha Moole, et al.
Published: (2015-10-01) -
Drug-induced liver injury with cholestasis in the neurologist and psychiatric practice
by: O. D. Ostroumova, et al.
Published: (2022-02-01)